Enlivex Therapeutics is focused on harnessing macrophages to treat inflammatory diseases through its cell therapy platform Allocetra™, which is designed for various therapeutic applications.

Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

ENLV

COM:ENLIVEX

Enlivex Therapeutics

0.97

−4.88%

0.08

Last Close

0.89

04/04 20:00

Market Cap

22.95M

Beta: -

Volume Today

105.67K

Avg: -

This will be loaded shortly.

Loading

This will be loaded shortly.

Loading

This will be loaded shortly.

Loading

name

homepage url

country

crunchbase url

employee count

sector

industry

Description

peer of

Metrics